"‘Salonpas Day' represents a day free from pain and it is important that people experience that pain relief safely," said John Incledon, President & CEO, Hisamitsu America, the marketers of Salonpas®, ...

Thinking about what’s next for your Hisamitsu Pharmaceutical shares? You’re not alone. Investors have been watching the stock with a curious mix of optimism and caution, especially after seeing it ...

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

Noven's Existing Operations to Serve as Combined Company's U.S. Growth Platform Miami, Florida USA and Tosu, Saga Japan, July 14, 2009 -- Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) and Hisamitsu ...

Hisamitsu Pharmaceutical Co ( (JP:4530)) has provided an announcement. Hisamitsu Pharmaceutical reported consolidated net sales of ¥114.5 billion for the first nine months of the fiscal year ending ...

MANILA, Philippines - Continuing to bring the benefits of patch treatment to the world, Hisamitsu Pharmaceutical Co. Inc., a world leader in the manufacture of external pain-relieving drugs, has ...

TORRANCE, Calif. Hisamitsu America on Thursday kicked off its “Join the Pain Free Movement” initiative, a media campaign to promote its line of Salonpas external pain-relief patches. “The ‘Join the ...

Hisamitsu Pharmaceutical surged the most in more than 47 years after the Japanese maker of pain-relief patches announced it would go private in a management buyout valued at about ¥457 billion ($2.9 ...

Miami-based Noven Pharmaceuticals is being snapped up by Japan's Hisamitsu Pharmaceutical for $430 million. The news was announced simultaneously with a release touting the positive data gathered in a ...

Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan. The company offers OTC products, such as external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from Hisamitsu ...

Hisamitsu becomes the fourth Japanese pharmaceutical company to announce a US acquisition in the recent past, as it makes a tender offer for transdermal and women's health company Noven. Japan's ...